Sergei Sobyanin held a video conference with members of the clinical Committee to combat coronavirus

Moscow mayor Sergei Sobyanin held a meeting in videoconference with medical members of the clinical Committee against COVID-19. It discussed issues related to organization of treatment of patients and measures to combat the pandemic.

the Mayor thanked all the medical workers that help the city in the fight against coronavirus infection: “I take this opportunity to Express my great appreciation to all the thousands, and now tens of thousands of physicians, medical staff, doctors, nurses, Junior staff, all those involved in this system. Thank you for your determination to stand in line and all together to do everything we can to defeat the growing threat, to save the citizens.”

however, he stressed that for a successful fight against coronavirus doctors and the Government should work as a team, and the whole system — from the doctor on call or to detect the disease at the clinic to hospitalization, treatment and subsequent discharge — must function as a single mechanism.

“each one of you, from your position, from understanding the problems depends on how effectively and safely we come out of this situation as saving the lives and health of Muscovites. I hope that as we worked as a team and will work to pass this difficult way”, — said Sergey Sobyanin.

to reduce the number of contacts residents and to prevent the rapid spread of infection was limited to the operation of enterprises of different industries, for residents, imposed a regime of isolation. From 15 April to move around the city in transportation necessary pass cards. To support residents and business affected by the restrictions, set allowances and subsidies, as well as adopted a number of other socio-economic measures.

“I today signed another decree aimed at supporting the business, saving jobs and the creation of a normal situation as possible under the circumstances. We all need to support each other and create a situation that would be acceptable to the city, and for medical systems. It is important to balance all of these units,” — said Sergey Sobyanin.

the Mayor also supported the proposal for the introduction of additional payments to blood donors who have had COVID-19 and have developed antibodies to coronavirus infection.

the Attraction of donors through incentives already proven effective in China, said the Director of the research Institute of emergency care named after N. In. Sklifosovsky Sergey Petrikov.

it is Expected that the transfusion of blood plasma with antibodies, will help patients to better tolerate coronavirus infection until, until there is a vaccine. “Complications were not any, and all patients who ��the plasma got, was not on a ventilator. It is clear that in order to speak about whether or not the technique, it is necessary to compare two groups: those with plasma and without plasma, but it’s not a matter of a few days”, — said Sergey Petrikov.

Clinical Committee COVID-19 — temporary collegial body established on the initiative of Moscow doctors. Its main tasks are:

— systematization of scientific and practical data about the clinical journey of a patient with a positive test result for coronavirus;

— development of the database for COVID-19 of the most relevant international and Russian clinical protocols and recommendations, scientific articles and research;

— the choice of optimal prevention, technologies of diagnostics, treatment and rehabilitation of patients;

— development of algorithms and requirements for the provision of health care to patients in outpatient and inpatient stage.

the clinical Committee is comprised of 22 professionals. Among them are representatives of the largest urban medical institutions engaged in treatment of patients with coronavirus infection: Director, Institute of emergency care named after N. In. Sklifosovsky Sergei Petrikov, the chief doctor of the medical centre Denis Protsenko, chief doctor of city clinical hospital No. 52 Maryana Lysenko, the chief physician of Station of ambulance and emergency care name A. C. Puchkova Nikolai plavunov, and others.

Also the Committee included experts of the Moscow Department of healthcare on subjects that are of direct relevance to the diagnosis and treatment of patients with coronavirus infection. For example, the chief non — staff pulmonologist Andrey belevskiy, chief freelance specialist — clinical pharmacologist Marina Zhuravleva, chief freelance specialist of primary medical and sanitary aid to adult population Andrew Tyazhelnikov and the chief expert on radiation and instrumental diagnostics Sergey Morozov.

the Committee has already implemented several initiatives. Thus was created a unified system of hospitals, which treat patients with coronavirus and community-acquired pneumonia. Now most pneumonia is due to a new type of coronavirus infectiei. This trend is particularly noticeable in the period of strengthening of the epidemic.

Also began to operate the new principles for the routing of patients, diagnosis and clinical decision-level admissions. When the evacuation to the hospital the patient is still no test results for coronavirus infection, but when examined in the emergency room on a computer tomogram reveal signs of pneumonia — COVID-19 with typical clinical manifestations, it hospitalitynet to the hospital and do patient with corenvirosell infection. This allows to speed up the provision of medical care.

CT-diagnosis has become a mandatory procedure when the diagnosis is confirmed COVID-19. The presence of a negative smear result in patients with signs of respiratory disease will not completely eliminate the presence of coronavirus. The only reliable study in this situation is computed tomography of the lungs. For CT diagnosis of the disease and prompt medical care to work connected more than 40 outpatient clinics.

Chief expert in radiation and instrumental diagnostics Sergey Morozov added that the training of doctors for CT in patients with COVID-19 goes for a few weeks.

“a Few weeks ago started webinars, distance learning program, and open course. We have registered several thousand people, including from the regions. Therefore, doctors understand how to do these studies. We verify all studies, identify those doctors who may be, there are some differences, and adjust accordingly. And plus, now adjusted to send the results of the studies in the Federal centers and hospitals. It’s pretty cool, because now when a patient is hospitalized, you don’t need to study,” he said.

in addition, there are transportation of discharged patients from hospitals to home. Soon the number of cars for this purpose it is planned to increase.

Chief physician of infectious hospital № 1 Svetlana Smetanina thanked the Mayor for giving me the car and said that is a tremendous help for patients undergoing COVID.

on April 14, the members of the clinical Committee met with representatives of delegation of medical experts from the people’s Republic of China. They discussed the issues of prevention, treatment and measures to prevent the spread of infection.

Under the supervision of the clinical Committee, together with the National research centre of epidemiology and Microbiology named after N. F. Gamalei is the realization of several important projects.

For example, create new test systems expert-level to detect genetic material of coronavirus by polymerase chain reaction. In addition, the development of specific diagnostic panel to determine the sensitivity and specificity used in a lab network test systems.

Also developed a diagnostic system for analysis of plasma patients a new type of coronavirus infection in the presence of neutralizing antibodies and diagnostic panel complexes cytokines to predict the characteristics of the course and the effectiveness of various m��of methods of treatment of the most severe patients.

in addition, experts are responsible for assessing the viral load in the background of the different treatment regimens of patients with COVID-19, testing several clinical test-systems for antibodies to SARS-CoV-2, to develop three-dimensional cultures of lung tissue for evaluation of the effectiveness of new drugs against SARS-CoV-2 and study the effectiveness of prophylactic ingestion of hydroxychloroquine among health professionals.

Great attention is paid to the selection of drugs for the treatment of a new type of coronavirus. You have to constantly adjust the list of drugs that can be applied depending on the stage of treatment and patient groups, to add new drugs.